Begin main content

Call for Patient Input: Xultophy

Published on: January 2, 2019
Result type: News

CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website.


Brand name Generic name Manufacturer Indication(s)
Xultophy insulin degludec + liraglutide Novo Nordisk Canada Inc. Diabetes mellitus, Type 2
Project Number Call for patient input Patient input deadline Submit patient input
SR0599-000 2019-01-02 2019-02-21 Submit